Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor
|
Scritto da Annals of the Rheumatic Diseases current issue |
We read with interest the paper by Mercer et al1 focusing on the risk of lymphoma in patients included in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BS ... ...
|
|
Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor by Nocturne et al
|
Scritto da Annals of the Rheumatic Diseases current issue |
We thank Nocturne et al1 for their interest and comments on our recent paper, which looked at lymphoma risk over the medium term in a cohort of patients receiving tumour necrosis factor inhi ... ...
|
What is rheumatoid arthritis Considering consequences of changed classification criteria
|
Scritto da Annals of the Rheumatic Diseases current issue |
Changes in classification criteria
Rheumatoid arthritis (RA) was recognised as a separate disease entity in the middle of the 20th century. Since then several sets of classification criteria were developed for use in clini ... ...
|
EULAR revised recommendations for the management of fibromyalgia
|
Scritto da Annals of the Rheumatic Diseases current issue |
Objective
The original European League Against Rheumatism recommendations for managing fibromyalgia assessed evidence up to 2005. The paucity of studies meant that most recommendations were ‘expert opinion’.
... continua Aggiungi commento
|
|
Consensus-based recommendations for the management of juvenile dermatomyositis
|
Scritto da Annals of the Rheumatic Diseases current issue |
Background
In 2012, a European initiative called Single Hub and Access point for pediatric Rheumatology in Europe (SHARE) was launched to optimise and disseminate diagnostic and management regimens ... ...
|
Patients with seronegative RA have more inflammatory activity compared with patients with seropositive RA in an inception cohort of DMARD-naïve patients classified according to the 2010 ACR/EU
|
Scritto da Annals of the Rheumatic Diseases current issue |
Objectives
To compare the presentation of seropositive and seronegative early rheumatoid arthritis (RA) in disease-modifying antirheumatic drug (DMARD)-naïve patients classified according to the 2010 American College of Rheu ... ...
|
Efficacy and safety of switching from reference infliximab to CT-P13 compared with maintenance of CT-P13 in ankylosing spondylitis: 102-week data from the PLANETAS extension study
|
Scritto da Annals of the Rheumatic Diseases current issue |
Objectives
To investigate the efficacy and safety of switching from infliximab reference product (RP) to its biosimilar or maintaining biosimilar treatment in patients with ankylosing spondylitis (AS). Methods... continua Aggiungi commento
|
|
|
Inizio Prec. 1 2 3 4 5 6 7 8 9 10 Succ. > Fine >>
|
Pag 1 di 735 |